4.4 Article

In vivo timing of onset of transgene expression following adenoviral-mediated gene transfer

Journal

VIROLOGY
Volume 308, Issue 2, Pages 243-249

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/S0042-6822(02)00138-1

Keywords

adenovirus; onset; gene therapy; lung; pseudotransduction; beta(2)-adrenergic receptor; alveolar fluid clearance

Categories

Funding

  1. NHLBI NIH HHS [HL-66211] Funding Source: Medline

Ask authors/readers for more resources

Recombinant adenoviruses are efficient gene transfer vehicles that could be used for treatment of acute diseases. However, the time required for adenoviruses to produce physiologically relevant levels of transgene in vivo is unknown. To address this question rat lungs were infected with an E1a(-)/E3a(-) adenovirus that contains an hCMV-driven human beta(2)-adrenergic receptor (beta(2)AR) cDNA. Human beta(2)AR message and protein expression were noted 2-4 h postinfection without evidence of pseudotransduction. beta(2)AR function (CAMP production) was increased at 6 h postinfection. To determine when beta(2)AR gene transfer affects downstream catecholamine-sensitive pathways, we measured lung Na,K-ATPase expression and alveolar fluid clearance (AFC). beta(2)AR gene transfer increased Na,K-ATPase number by 80% at 6 h, and AFC by 20% at 8 h postinfection. These data indicate that recombinant adenoviruses can produce physiologically significant levels of transgene within hours of infection and that they may be suitable for gene therapies for acute, rapidly progressive diseases. (C) 2003 Elsevier Science (USA). All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available